zyxwvutsrqp
zyxwvutsrqpo
zyxwvutsrq
zyxwvutsrqp
Eur. J. Biochem. 179,651 -657 (1989)
FEBS 1989
Synthesis of glycoconjugates derived from various lipopolysaccharides
of the Vibrionaceae family
Joseph H. BANOUB, Derek 11. SHAW, N. Anthony NAKHLA and Howard J. HODDER
Department of Fisheries and Oceans, Experimental Sciences Division, St. John's, Newfoundland
(Received April b/October 5, 1988) - EJB 88 0401
zyxwvut
zyxwvu
Conjugation of simple ketoses (such as 3-deoxy-~-manno-2-octu~osonic
acid and N-acetylneuraminic acid) and
of various 0-specific polysaccharides (from Aerornonas hydrophila and Aeromonas salmonicida) to the bifunctional
spacer 2,6-hexanediamine, was achieved by reductive amination. The saccharide - 1-(ti-amino)-hexanealkyamines
obtained were converted into the corresponding isothiocyanate derivatives and coupled to the free c-amino group
of lysine residues of the protein carrier bovine serum albumin. In similar manner, the aldehyde group introduced
by selective periodate oxidation into the partially 0-deacylated lipopolysaccharide of Vibrio anguillarum was
conjugated to 1,6-hexanediamine, converted into the corresponding isothiocyanate and covalently attached to
bovine serum albumin.
During the past decade, artificial glycoconjugates or
This paper presents a new method for coupling different
neoglycoproteins, obtaincd by covalent attachment of poly- 0-specific polysaccharides and a partially 0-deacylated
saccharide to protein, have been extensively used for anti- oxidized lipopolysaccharide of representative species of the
body -polysaccharide interactions [l] and found to be of Vibrionaceae family to the lysine residues of the carrier progreat utility as vaccines against encapsulated bacteria [2].
tein bovine serum albumin. The method presented here is
Numerous methods, each with their own merits and pur- based on the attachment of the new spacer (or bridging arm)
poses, have been developed for the synthesis of glycocon- 1,6-hexanediamine, by reductive amination, to the ketonic
jugates [3]. Most of these studies have generally resorted to carbonyl group of the only dOclA residue of the corethe use of naturally occurring bacterial oligo- and polysac- oligosaccharide portion [lo, 111 of the native 0-specific
charides or chemically synthesized carbohydrate haptens polysaccharides of Aeromonas hydrophila and Aeromonas
which mimic the natural saccharide sequences of the carbo- salmonicida and to the core heptose aldehyde group of the
hydrate portion of the conjugate. One method that is both partially deacylated oxidized lipopolysaccharide of Vihrio
simple and effective is the direct covalent attachment of reduc- mguillarum [ 121. The polysaccharide - 1-alkylamine derivaing carbohydrates to the amino groups of proteins by re- tives obtained are purified and converted into the correspondductive amination using sodium cyanoborohydride [4, 51. A ing (6-isothiocyanato)-hexane alkylamine derivatives and
major disadvantage of this method is the opening of the ring then coupled to the lysine residues of bovine serum albumin
structure of the terminal reducing sugar to generate an acyclic by the procedure of McBroom et al. [13].
amine which, in certain cases, could be detrimental to the
biological specificities of the glycoconjugate [6].However, this
disadvantage is of no importance if the haptenic saccharide is MATERIALS AND METHODS
large, as in the case of bacterial polysaccharide [7]. Another
Bacterial cultures
drawback to this method is that it is not possible to conjugate
oligosaccharides having reducing ketose residues, such as the
A virulent strain of Aeromonas hydrophila (strain SJ-44)
terminal 3-deoxy-~-manno-2-octulosonk
acid (dOclA), to was obtained from Dr R. Lallier (Faculty of Veterinary Mediproteins [8]. This is consistent with the fact that a successful cine, University of Montreal, St Hyacinthe, Quebec). The
reductive amination attachment of oligosaccharides contain- virulent strains of Aeromonas sulmonicida (strain SJ-15) and
ing terminal dOclA residues to proteins can be achieved only Vihrio anguillarum (strain SJ40T) were kindly supplied by Dr
if a functionalized spacer molecule is introduced at the ketonic T. P. T. Evelyn (Pacific Biological Station, Nanaimo, BC).
carbonyl group of dOclA [8, 91.
Correspondence to J. H. Bdnoub, Department of Fisheries and
Oceans, Experimental Sciences Division, Science Branch, P. 0. Box
5667, A1C 5x1 St. John's, Newfoundland, Canada
Abbreviation$. Albumin, bovine serum albumin; 0-specific
polysaccharide is defined as the combined 0-chain polysaccharide/
core oligosaccharide portion of the lipopolysaccharide; LD-Hep,
L-g!ycero-D-manno-heptose; L-Rha, 1.-rhamnose; L-Qui3NAc, 3-acelamido-3,6-dideoxy-~-glucosc
; D-QuI~NAc,
2-acetamido-2,6-dideoxyD-glucose: dOclA, 3-deoxy-~-rnanno-2-octulosonic
acid.
zyxw
Purification and hydrolysis of the lipopolysaccharides
Lipopolysaccharides were extracted from lyophilized bacterial cells by the aqueous phenol method and were recovered
as previously described [12, 14, 151. Production of the
0-specific polysaccharides was achieved by hydrolysis of the
lipopolysaccharide in 1 %, aqueous acetic acid for 90 min at
100"C, followed by gel chromatography on Sephadex G-50
as previously described [12, 14, 151.
652
zyxwvutsrqpo
Chemicals
Crystalline bovine serum albumin (referred to as ‘albumin’
here) was obtained from Schwarz-Mann (Orangeburg, NY)
and 1,6-hexanediamine hydrochloride from Pfaltz and Bauer
(Waterbury, CT); N-acetylneuraminic acid, the crystalline ammonium salt of dOclA and sodium cyanoborohydride were
obtained from Sigma Chemical Co. (St Louis, MO).
Ana(yticu1procedures
Protein was measured by the method of Lowry et al. [16]
and sugars were measured by the procedure of Dubois et al.
[17]. Unconjugated lysine was determined with an amino acid
analyzer using albumin as a standard. The molecular masses
of the glycoconjugates were determined by gel filtration
chromatography as described by Hopwood and Robinson
[18]. Thin-layer chromatography was used to differentiate
between dOclA or N-acetylneuraminic acid and their
alkylamine derivatives. TLC analysis was carried out on
0.25-mm precoated plates of silica gel 60F254 (E. Merck,
Darmstadt, FRG) developed with chloroform/methanol/
water (10: 3: 1, by vol.). 13C-NMRspectra of the 1-(6-amino)hexane alkylamine derivatives of dOclA and N-acetylneuraminic acid were measured in DzO, with a Varian CFT20 spectrometer operating at 20 MHz in the pulse Fouriertransform mode with complete proton decoupling. Chemical
shifts are reported downfield from external tetramethylsilane.
into their corresponding 1-(6-isothiocyanato)-hexane alkylamine derivatives by the method of McBroom et al. [13].
Preparution of the 0-specifi:c-polysuccharideI - (6-isothiocyanato)-hexaneulkylamine derivatives
The O-specific polysaccharide (30 pmol: A . hydrophila,
159 mg; salmonicidu, 313.5 mg) was dissolved in water ( 5 ml).
This solution was added to a rapidly stirred mixture, adjusted
to pH 8.0, of sodium cyanoborohydride (0.3 mmol) and 1,6hexanediamine hydrochloride (3 mmol) in water ( 2 ml). The
reaction was allowed to proceed for 48 h while maintaining
constant pH by titration with 0.1 M sodium hydroxide. The
reaction mixture was then applied to a column of Bio-Gel P-2
(2.5 x 90 cm) and eluted with 0.1 M acetate pH 5.0. Fractions
were collected and assayed for carbohydrate and checked by
13C-NMR for the incorporation of the alkylamine spacer.
The O-specific-polysaccharide- 1-(6-amino)-hexane alkylamine derivatives were converted into the corresponding
1-(6-isothiocyanato)-hexane derivatives as follows. To
24 pmol of the O-specific-polysaccharide - 1 -(6-amino)-hexane alkylamine derivative dissolved in 80% aqueous ethanol
(2 ml), thiophosgene (1.3 mol) was added dropwise, while a
constant pH of 7.0 was maintained by titration with 1 M
sodium hydroxide in 80% aqueous ethanol. When consumption of sodium hydroxide had ceased, the reaction mixture
was freed of excess thiophosgene by repeated evaporation
with methanol; the yellow product was dried under vacuum.
z
zyxwvutsrq
zyxwvutsrqp
zyxwvuts
General conditions ,for coupling dOclA
and N-acetylneuraminic acid to the spacer I ,&hexanediamino:
preparation of the 1-(6-amino)-hexane alkylamine derivatives
Method A . The conjugation of dOclA to 1,6-hexanediamine hydrochloride was carried out using a modification
of the Svenson and Lindberg method [19]. dOclA (23.8 mg,
0.1 mmol) was dissolved in water (15 ml) and adjusted to
pH 10 with 0.1 M sodium hydroxide. This was then added to
a rapidly stirred mixture of 1,6-hexanediamine hydrochloride
(10 mmol) and sodium cyanoborohydride 0.06 g (1 mmol)
pre-adjusted to pH 8.0. The reaction was allowed to proceed
at room temperature for 48 h with the pH controlled at 8.0
by addition of 0.1 M sodium hydroxide. The reaction mixture
was then applied to a column of Bio-Gel P-2 (2.5 x 90 cm)
in distilled water adjusted to pH 6.0 with dilute acetic acid.
Fractions were assayed for carbohydrate and the purity of
the dOclA - 1-(6-amino)-hexane alkylamine derivative was
checked by I3C-NMR.
Method B. The conjugation of N-acetylneuraminic acid
to 1,6-hexanediamine hydrochloride was carried out under
similar conditions to the procedure of Roy et al. [8]. NAcetylneuraminic acid (100 mg, 0.32 mmol) was dissolved in
0.2 M phosphate buffer ( 5 ml) at pH 6.0. To this solution
sodium cyanoborohydride (201 mg, 3.2 mmol) and 1,6-hexanediamine (3.71 g, 32 mmol) were added. The reaction was
allowed to proceed for 24 h at pH 6.0. The reaction mixture
was then applied to a Sephadex G-I 5 column (1.5 x 90 cm)
made up in distilled water adjusted to pH 6.0 with acetic acid.
Fractions were assayed for carbohydrate and the purity of
the N-acetylneuraminic-acid - 1-(6-amino)-hexane alkylamine
derivative was checked by 13C-NMR.
Formation of the saccharide-albumin glycoconjugates
The 1-(6-isothiocyanato)-hexane alkylamine derivatives of
dOclA and N-acetylneuraminic acid and the corresponding
O-specific polysaccharides were covalently attached to the
free &-aminogroup of the lysine residues of the protein carrier
bovine serum albumin. The saccharide-isothiocyanate derivatives (177 pmol) dissolved in phosphate buffer at pH 9.0
(2 ml), were each added to a rapidly stirred solution of albumin (I pmol) dissolved in the same buffer. The reactions were
allowed to proceed for periods varying over 48 - 96 h at room
temperature, while the pH was maintained constant by titration with 10mM sodium hydroxide. The coupling was
assumed to be complete when consumption of sodium hydroxide had ceased; the resulting glycoconjugates were extensively dialyzed against distilled water and freeze-dried.
The glycoconjugates were purified by gel chromatography
on Bio-Gel P-150 (2.50 x 90 cm) eluted with 0.1 M phosphate
pH 9.0. Fractions were assayed for carbohydrate and protein.
zyxwvutsrqpo
Preparation of the partially O-deacylated oxidized
lipopolysaccharide - I - (6-isothiocyanato)-hexane alkylamine
derivative and its ulbumin glycoconjugate
V . anguillarum lipopolysaccharide (100 mg, 9.9 pmol) was
dissolved in 0.25 M sodium hydroxide (5 ml) and heated at
56 T in a water bath for 60 min. The solution was cooled to
room temperature and centrifuged at 2000 rpm for 15 min at
4°C. The pellet was discarded and the supernatant neutralized
with acetic acid, dialyzed against distilled water and
lyophilized. The partially O-deacylated lipopolysaccharide
obtained was dissolved in 0.1 M sodium metaperiodate
(10 ml) and placed in the dark for 15 min at room temperature; ethylene glycol (2 ml) was then added to the reaction
mixture. The solution was extensively dialyzed and subsequently lyophilized.
zyxwvutsr
Preparation of the I- (6-isothiocyanato)-hexanealkylamine
derivatives o f dOclA and N-acetylneuraminic acid
The 1-(6-amino)-hexdne alkylamine derivatives of N-acetylneuraminic acid or dOclA (0.3 mmol) were transformed
z
zyxwvuts
653
The partially 0-deacylated oxidized (i.e. modified) lipopolysaccharide (89 mg z 8.8 pmol) was dissolved in water and
adjusted to pH 10. This solution was added to a rapidly stirred
mixture (adjusted to pH 8.0) of sodium cyanoborohydride
(0.9 mmol) and 1,6-hexanediamine hydrochloride (9 mmol)
in water (2.0 ml). The reaction was allowed to proceed for
48 h while maintaining constant pH. The reaction mixture
was then processed as described earlier and converted into
the 1-(6-isothiocyanato)-hexane alkylamine derivative by the
procedure of McBroom et al. [13].
The modified-lipopolysaccharide - 1-(6-isothiocyanato)hexane alkylamine derivative (8 pmol) dissolved in phosphate
buffer pH 9.0 (2 ml) was added to a rapidly stirred solution
of albumin (0.08 pmol) dissolved in the same buffer. The
reaction was allowed to proceed for 48 h at room temperature
and processed as previously described. The glycoconjugate
was purified by gel chromatography on Bio-Gel P-150eluted
with 0.1 M phosphate pH 9.0.
buffer ions [8]. By varying these parameters, successful
covalent attachment of oligosaccharides having aldose end
groups to protein carriers was achieved [22, 231, whereas no
direct coupling of ketoses to proteins has been observed [8,
241. Roy et al. have indicated that the unsuccessful coupling
of ketoses to proteins was due to the lower reactivity of the
ketonic carbonyl group of the ketose residue as compared to
the aldehydic group, in addition to steric effects introduced
by using a large macromolecular protein carrier as a receptor
molecule [8]. They concluded that the conjugation of terminal
ketose residues of oligosaccharides to proteins, by reductive
amination, would require the introduction of a small
functionalized spacer molecule at the ketonic carbonyl group
[8]. This conclusion was based on the fact that a successful
conjugation of dOclA by reductive amination was achieved
using an excess of the small receptor glycine molecule [8]. We
therefore chose to use 1,6-hexanediamine as a novel bifunctional spacer (during the conjugation of dOclA by reductive
amination) as it leaves the unconjugated functional 6-amino
group free for further chemical manipulation aimed at
covalent attachment to carrier proteins.
Hence 3-deoxy-~-manno-2-octu~osonic
acid (0.1 mmol)
was reacted with an excess of the novel spacer 1,6-hexanediamine (10 mmol) in the presence of sodium
cyanoborohydride. At pH 8.0, the imine derivative (Fig. 1)
formed between the ketonic carbonyl group and the primary
amino group of the spacer, was selectively reduced to the
secondary amine to form the dOclA - 1-(6-amino)-hexane
alkylamine derivative 2,1 3 C - N M R (DzO); G/ppm = 174.10
(C-1, carboxylic acid), 78.82 (C-4), 75.76 (C-5), 74.54 (C-6),
72.03 (C-7), 64.20 (C-8), 47.84 (C-2), 40.40 (C-3 and a-CH2,
spacer), 27.54 (B-CH,, spacer) and 26.13 (7-CH2, spacer).
This latter compound was subsequently transformed into the
dOclA - 1-(6-isothiocyanato)-hexane alkylamine derivative
3 . The conversion of the isothiocyanate derivative from
the compound 2 was almost quantitative.
Similarly, N-acetylneuraminic acid was conjugated to the
1,6-hexanedkamine spacer using the molar ratio of sugar/reducing agent/spacer of 1 : 10: 100; these are similar proportions of the dOclA conjugation. The N-acetylneuraminicacid - 1-(6-amino)-hexane alkylamine derivative showed the
following 13C-NMR(D20):G/ppm = 175.60 (C-I, carboxylic
acid), 174.88 (CO, NHAc), 71.83 (C-8), 70.42 (C-6), 68.70
(C-7), 68.07 (C-4), 64.35 (C-9), 55.07 (C-2), 47.91 (C-5), 40.45
(a-CH2, spacer), 35.19 (C-3), 27.54 (8-CH2, spacer), 26.22
(y-CH2, spacer) and 23.03 (CH3, NHAc). This latter compound was subsequently transformed into the corresponding
isothiocyanate derivative.
zyxwvuts
zyxwvu
zyxw
zyxwvutsrqp
Immunization procedures
New Zealand white rabbits (approximate mass 2 - 3 kg)
were immunized intravenously [20] on five successive days
with increasing amounts (0.66 - 3.4 kg) of the various conjugates. A booster dose of 3.4 pg was administered 15 days after
the last injection and the rabbits were bled 10 days later.
Immunodiffusion
Double radial immunodiffusion was performed in 0.9%
agarose gels in phosphate-buffered saline containing 2% poly(ethylene glycol) ( M , 4000) [21].
Passive hemagglutination
Passive hemagglutination tests were carried out in
microtiter plates (Linbro Division, Flow Laboratories, Inc.,
Hamden, CN). Human type 0 erythrocytes (1 YOsuspension in
phosphate-buffered saline) were incubated with alkali-treated
lipopolysaccharide preparations (0.25 M NaOH at 56 "C for
60 min) at a concentration of 30 pg/ml for 90 min, at 37°C.
The coated erythrocytes were then washed five times with
phosphate-buffered saline. For titration of antisera, 25 p1
0.5% erythrocyte suspension was mixed with 25 pl serum
(twofold dilutions) and left at room temperature for 2 h. The
serum titre was the highest dilution of the serum giving maximal strong hemagglutination. Previously prepared rabbit antisera to the lipopolysaccharides of A . salmonicida and V.
anguillarum and also to whole cells of V . anguillarum were
also used as reference antisera.
RESULTS
N
zyxwvutsrqp
zyxwvutsrqp
zyxwvuts
Preparution of the I - (6-isothiocyanato)-hexane alkylamine
derivutives o j 3-deoxy-o-manno-2-octulosonic acidand N-aretylneuraminic acid
It has been shown that the amount of the cyclic form of
a reducing sugar is the rate-limiting step in the reductive
amination reaction using sodium cyanoborohydride, and also
that it is dependent on temperature, pH and the presence of
Preparation of the 0-specific-polysuccharide I - (6-isothiocyanuto)-hexane alkylarnine derivatives
Conjugation of' the 0-spectfic polysaccharide of A. hydrophila to the 1,6-hexanediamine spacer and formation of the
corresponding isothiocyanate derivative. A . hydrophila is a
gram-negative bacterium associated with both aquatic and
terrestrial environments. Classically, the species has been regarded as an opportunistic pathogen of freshwater fish. The
chemical structure of the repeating unit [14] of the native
0-specific polysaccharide (of strain SJ-44) is indicated in the
following structure.
OAC (21 %)
I
2
[4)-a-~-Rhap-(
1+3)-jl-~-GlcpNAc-(l] 4core oligosaccharide 1+ dOclA
654
zyxwvutsrqp
cot -No+
I
I
CHI
I
nocn
I
nocn
I
CHOH
I
C=NICH21,NHz
I
I
CHOH
F"""
CHOH
zyxwvutsrqpo
zyxwvutsrqponmlkjih
zyxwvutsr
zyxwvutsrqp
zyxwvutsrqp
zyxwvutsrqponmlk
zyxwvutsr
zyxwvut
I
I!HzOH
CH2OH
I
~.
...........
kH
C02-Na'
I
S
I
"
I
c=o
I
F
CHNHICHZIINH C NHICHZI, H
NaCNBH,
I
I
cwz
I
HOCH
I
HOCH
I
cnon
I
C HOH
I
CHNHICHZII
NH
FHZ
I
c=o
HO&i
. .......~~
-
rlOFH
COz -No'
COz -NO'
B S A
,,,'
I
CHOH
I
CHOH
I
+.
I
CSCI,
~HOCH
I
Hocn
I
I
CHOH
I
CHOH
CHIOH
2
4,
I
CHNHICHzI( NHz
y 2
CHpOH
CH~OH
N=C= 5
2
Fig. 1. Covalent atfachmenfofthe I-(6-isothiocyanato)-hexanealkylamine derivative of dOclA to the €-aminogroups of albumin Iysine residues.
BSA = bovine serum albumin
The dOclA reducing end of the core-oligosaccharide portion
of the 0-chain polysaccharide was reacted with an excess
of the spacer 1,6-hexanediamine in the presence of sodium
cyanoborohydride at pH 8.0. The resulting O-specificpolysaccharide - 1-(6-amino)-hexane alkylamine derivative
was purified by gel chromatography and then transformed
into the corresponding (6-isothiocyanato)-hexane alkylamine
derivative.
Conjugation of the 0-specific polysaccharide of A. salmonicida to the I,6-hexanediamine spacer and Jormation of
the corresponding isothiocyanate derivative. The bacterium A .
salmonicida is the causative agent of furunculosis in salmonid
fishes and is an important pathogen causing high mortalities
is aquaculture and fish hatchery operations. The chemical
structure of the repeating unit of the native 0-specific
polysaccharide [15] is indicated in the following structure.
and the corresponding 0-specific polysaccharides to the free
&-aminogroup of the lysine residues of albumin was achieved
by reacting an excess of the saccharide isothiocyanate derivative (177 pmol) dissolved in the same buffer at pH 9.0 to
1 pmol albumin dissolved in the same buffer.
The relative amounts used for the formation of the
saccharide-albumin glycoconjugates were optimized, based
on the premise that the highest degree of substitution of the
lysyl residues in albumin by the dOclA-l-(6-isothiocyanato)hexane alkylamine derivative was achieved at a molar ratio
of ligand/individual lysyl group of about 3 : 1 [8]. Using this
ratio, the dOclA-albumin and N-acetylneuraminic-acid albumin glycoconjugates were obtained; virtually all of the
59 available lysine residues were derivatized.
For the 0-specific-polysaccharide - albumin glycoconjugates of A . hydrophila and A . salmonicida approximately
zyxwvutsrqpo
a-D-Glcp (35%)
1
1
4
X-D-GIC~
1
1
3
OAc (75%)
1
4
[+4)-a-Rhap-(l-t3)-P-~-ManpNAc-(l]~~
-core oligosaccharide 1+dOclA
The native 0-specific polysaccharide of A . salmonicida has a
core oligosaccharide containing a terminal dOclA reducing
residue. The conjugation of t h s 0-specific polysaccharide
was performed essentially under the conditions used for A .
hydrophila (see above).
10 mol polysaccharide/mol albumin was introduced, using the
same conditions. The chemical composition of the
glycoconjugates was determined by measurement of protein
and carbohydrate content, and molecular mass, as described
in Materials and Methods. The degree of conjugate substitution was also confirmed by the amount of unconiugated
lysine residues, as indicated by amino acid analysis. This deFormation qf the saccharide - albumin glyconjugates
gree of substitution was not immoved when the ratio of the
Covalent attachment of the 1-(6-isothiocyanato)-hexane igand to individual lysyl groupwere changed to 1 : 1, 2: 1, or
alkyldmine derivatives of dOclA and N-acetylneuraminic acid 5 :1 .
z
zyxwvu
655
0)
0 - SPECIFIC POCYSACCHARIM
b)
Q- SPECIFIC POLYSACCHAROE
LIPID A
CORE
OLIWSACCHARIDE
DEACYLATED
LIPID A
I1 NH,ICH,l,NH2,NaBH,CN
zyxwvutsrqpo
zyxwvut
zyxwvutsrqponmlk
zyxwvutsrq
21
csc12
CHNH (CH,I, N = C= S
C)
~I ~ C I F POLYSACCHARN
I C
OL IGOSACCHARIDE
I
zyxwvutsrqpo
zyxwvuts
zyxwvutsrq
d)
Q - SPECIFIC POLYSACCHARIM
CORE
DEACYLATED
LIPID A
OL IGOSACCHARIDE
0
Fig. 2 . Formation of modifird-lipopolysaccharide -albumin conjugate. ( a ) Intact lipopolysaccharide; (b) partially deacylatcd and selcctively
oxidized lipopolysaccharide (i.e. modified lipopolysaccharide); (c) 1-(6-isothiocyanatoz)-hexane alkylamine dcrivative of modified
lipopolysaccharide; (d) modified-lipopolysaccharide-albumin conjugate. BSA = bovine serum albumin
Preparation of the 1- (6-isothiocyanato)-hexaneulkylumine
derivative of purtially 0-deacylated oxidized V. anguillarum
lipopolysaccharide and its albumin glycoconjugute
V. anguillarum, a gram-negative bacterium belonging to
the family Vibrionaceae, is an important pathogen of marine
and estuarine fish, causing the hemorrhagic septicemia vibriosis. The chemical structure of the 0-specific polysaccharide
of the phenol-soluble cellular lipopolysaccharide is as follows
[12], where R is a propionyl group.
the core oligosaccharide of A . hydrophila chemotype I [27]
directly to albumin by the method of McBroom et al. [13],
without the introduction of the spacer molecule. This method
proved to be unsuccessful.
We have established that only the terminal non-reducing
LD-heptosyl residue of the inner region of the core
oligosaccharide of V . unguillarum would be susceptible to
a selective rapid periodate oxidation yielding a D-mannosyl
residue possessing an aldehyde group at C-6 (see Methods).
It thus became essential to modify the complete V . anguillurum
B-~-Quip3NAc-(l[
-+~)-P-L-Q~~~~NAC-(~+~)-~-L-QU~~~NAC-(~-]
4
2
t
OMe
7
1
a-~-Quip2NAc
314
T
R
The inner region of the core oligosaccharide of V. anguillurum,
which is essentially identical to that of the various A.
hydrophila chemotypes [25-281, is composed of a doubly
branched L-glycero-D-manno-heptose substituted by other
sugar residues in thc following manncr.
L-a-D-Hepp
1
1
6
-+ 3)-L-a-D-Hepp-(l +dOclA
4
T
1
~t-~-GlcpN-(l+7)-~-a-~-Hepp
Although the inner region of the core oligosaccharide of
V . anguillurum contains a 2-amino-2-deoxy-~-ghcoseresidue
having a free amino group, which conceivably could react
with thiophosgene and then act as a coupling site in formation
of the glycoconjugate. We have therefore attempted to couple
lipopolysaccharide in order to introduce an aldehyde group
at C-6 of the terminal non-reducing Lu-heptosyl residue in the
inner-core region. This free aldehyde group could then be
conjugated to the spacer 1,6-hexanediamine. It is known that
lipopolysaccharides are capable of eliciting pathophysiological toxic effects, known as endotoxic effects [29], which
are caused by the lipid A portion and that partially deacylated
lipid A and lipopolysaccharide samples are considerably less
toxic than the natural preparation by a factor of lo3 [29].
Therefore, it was logical to use a partially deacylated oxidized
lipopolysaccharide for conjugation to the spacer 1,6-hexanediamine for potential preparation of an albumin
glycoconjugate. Hence, the partially 0-deacylated V.
anguillurum lipopolysaccharide was selectively periodateoxidized and the product was reacted with an excess of 2,6hexanediamine in the presence of sodium cyanoborohydride
at pH 8.0 (Fig. 2). The resulting modified 1-(6-arnino)-hexane
alkylamine lipopolysaccharide derivative was purified and
converted into the isothiocyanate derivative as described for
the other saccharides. This derivative was then covalently
656
zyxwvutsrqp
zyxwvu
6
has been shown that immunization with the purified O-antigen is rarely successful as this fraction is usually nonimmunogenic due to it small molecular size [33]. In order to
render the polysaccharide immunogenic, it has to be
covalently linked to a suitable larger carrier molecule 1321.
We have suggested that in lipopolysaccharides of the
Vibrionaceae family there is only one dOclA residue (in contrast to enterobacterial lipopolysaccharides) which connects
the native polysaccharide to the lipid A [lo]; it has been
established that this residue exists in the furanose form in a
mutant of Arromonas salmonicida and is substituted through
C-6 [ll].
The novel synthesis of glycoconjugates presented in this
paper is tailor-made for the various 0-specific antigens derived from Vibrionaceae lipopolysaccharides. It is based on
the introduction of the 1,bhexanediamine to the only terminal
reducing dOclA residue of the core oligosaccharide portion
of the native 0-specific polysaccharides.
The anticipated success of this synthesis of glycoconjugates was based on experimental results of covalent attachment by reductive amination of simple ketose monosaccharides such as dOclA and N-acetylneuraminic acid to the spacer
1,6-hexanediamine. To our knowledge, this spacer has not
previously been used for glycoconjugate syntheses. It was
originally uscd for the covalent attachment of an active-sitedirected inhibitor of human leukocyte elastase to the
microspheres of human albumin as a potential therapeutic
agent for emphysema [34]. It has been shown by Lemieux et
al. [35, 361 that the introduction of a bridging arm, composed
of a polymethylene chain between the haptenic polysaccharide
and the protein carrier, produced antisera that mainly recognized the epitopes of the polysaccharide portion of the
glycoconjugate.
One of the primary amino groups of the 1,6-hexanediamine spacer was introduced in the dOclA terminal-reducing residue of the core oligosaccharide portion of the native
0-chain polysaccharide of A . hydrophila and A . salmonicida,
under very mild conditions at pH 8.0 by reductive amination.
After subsequent conversion to the corresponding polysaccharide-isothiocyanate derivatives, they were covalently attached to the free ,+amino group of lysine residues of the
carrier protein bovine serum albumin. The resulting glycoconjugates were immunogenic and elicited both anti-haptenic and
anti-albumin antibodies in rabbits.
It has been shown that free aldehydic groups can be used
successfully in the conjugation of bacterial capsular polysaccharide to proteins as potential human vaccines [36]. It was
therefore reasonable to expect that a similar modification
could be introduced in lipopolysaccharide molecule. It has
also been known for quite some time that deacylated lipid A
and lipopolysaccharide are considerably less toxic than the
parent preparation [29] and it is anticipated that conjugation
of deacylated lipopolysaccharide to a protein carrier will
break down the endotoxic conformation of these molecules
[29], rendering them considerably less toxic and making them
more amenable for potential vaccine use. The V . anguillarum
lipopolysaccharide was partially 0-deacylated with mild
alkali and modified by selective oxidation of periodate-sensitive terminal core heptose. Attempts at direct covalent attachment of this modified lipopolysaccharide to albumin by reductive amination were unsuccessful ; however, this can be
circumvented by the introduction of the spacer 1,6-hexanediamine to the freed aldehyde group obtained (see Fig. 2).
As mentioned earlier, the 0-specific polysaccharide of V.
anguillarum is a short heteropolymer of a main chain of
zyxwvutsrqpo
zyxwvutsrqp
zyxwvutsr
zyxwvutsrq
zyxwvu
Fig. 3 . Passive hemag~hrtinatiun ritres of' sera to V. anguillarum
lipupol~,.sac.c'liuri~~
and lipopol~saccharide-albumin conjugate. The
titres of V. mnguillarurn SJ40T lipopolysaccharide (filled blocks) and
its albumin conjugale (shaded blocks) wcre measured against (A)
antiserum to V. anguillarum SJ40T lipopolysaccharide and (B) antiserum to whole cells of V. anguillarurn SJ-43
attached to the protein carrier bovine serum albumin (Fig. 2);
the molar ratio of ligand/individual lysyl group was 1.7:l.
It was calculated that in this modified-lipopolysaccharide albumin glycoconjugate an average of 14 molecules modified
lipopolysaccharide/moleculealbumin was introduced.
Immunological properties
of the saccharide-albumin glycoconjugates
The Q-specific-polysaccharide - albumin glycoconjugates
of A . h-ydrrophila and A . salmonicida and the modifiedlipopolysaccharide - albumin glycoconjugate of V . anguillarum were used as immunogens in rabbits; the antisera were
evaluated by immunodiffusion and passive hemagglutination.
The immunodiffusion experiments with the respective
saccharide-albumin glycoconjugates indicated that these conjugates produced antibodies that gave precipitin lines against
their homologous lipopolysaccharides.
Passive hemagglutination experiments were performed
with the respective antisera to the various saccharide-albumin
glycoconjugates and their alkali-treated homologous lipopolysaccharides. In rabbits immunized with the individual
saccharide-albumin glycoconjugates of A . hydrophila and A .
salmonicida, reasonable titres of 320 and 1280, respectively,
were obtained. In the modified-lipopolysaccharide - albumin
glycoconjugate of V. anguillarum, a titre of 640 was obtained.
Comparative hemagglutination experiments carried out with
antisera to V . anguillarum SJ-40T lipopolysaccharide and the
whole cell of a different strain, V . anguillarum SJ-43, showed
that the antigens of V. anguillarum SJ40T lipopolysaccharide
and its modified albumin glycoconjugate had exactly the same
titres (see Fig. 3).
zyxwvu
DISCUSSION
The significance and severity of bacterial fish diseases
caused by various species of the Vibrionaceae family have
increased with the development and expansion of commercial
aquaculture [30]. These ventures are increasingly relying on
vaccination for disease control.
The crude empirical approach using whole cells of killed
bacteria as vaccines has prompted the development of novel
methods directed toward usage of the cell-surface lipopolysaccharide antigen as a vaccine. It has been shown that
Vihrio anguillarum lipopolysaccharide protects fish against
vibriosis infections [31]. The protective value of such vaccines
has long been attributed to the anti-0-antigen moiety 1321; it
z
zyxwvutsrq
zyxwvutsr
657
zyx
13. McBroom, C. R., Samanen, C. H. & Goldstein. I. J. (1972)
Methods Enzymol. 2NB, 212-219.
14. Shaw, D. H. & Squires, M. J. (1984) FEMS Microhiol. Lett. 24.
277 - 280.
15. Shaw, 1).H., Lee, Y.-Z., Squires, M. J. & Luderitz, 0. (1983)
Eur. J. Biochem. 131, 633 -638.
16. Lowry, 0. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J.
(1 951) J . B i d . Chcvn. 193, 265 - 275.
17. Dubois, M., Gilles, K. A,, Hamilton, J . K . , Rebers, P. A. &
Smith, F. (1956) Anal. Chem. 28, 350-356.
18. Hopwood, J. J. & Robinson, H. C . (1973) Biochem. J. 135,631 637.
19. Svenson, S. B. & Lindberg, A. A. (1979) J. Immunol. Methods 25,
323 - 335.
20. Neter, E . (1956) Bactrriol. Rev. 20, 166-188.
21. Ouchterlony, 0. (1963) Prog. Allergy6, 30-154.
22. Danielson. S. J. & Gray, G. R. (1986) Glycoconjugate J . 3, 363377.
23. Makhlouf, S. E., Davis, L. E., Deepika, P. &Anderson, B. (1986)
Glycoconjugate J . 3,351 - 362.
24. Lee, H. S., Sen, L. C., Clifford, A. J., Whitaker, J. R. & Feeney,
R. E. (1979) J . Agric. Food Chem. 27, 1094- 1098.
25. Banoub, J. H., Michon, F., Shaw, D. H. & Roy, R. (1984)
REFERENCES
Carhohydr. Rus. 128,203- 21 6.
26. Banoub, J. H., Choy, Y.-M., Michon, F. & Shaw, D. H. (1983)
1. Stowell. C. P. & Lee. Y. C. (1980)
,
, Adv. Curhohvdr. Chem. BioCarhohydr. Res. 114, 267 - 276.
chem. 37, 225 -281.
27. Michon, F., Shaw, D. H. & Banoub, J. H. (1984) Eur. J . Biochem.
2. Lee, C.-J. (1987) Mol. Immunol. 24, 1005-1019.
145, 107-114.
3. Aplin, J. D. & Wriston, J. C., Jr (1981) C R C Crit. Rev. Biochem.
28. BdnOUb, J. H. & Shaw, D. H. (1981) Ccirhohydr. Res. Y8, 9310,1259 - 1306.
103.
4. Gray, G. R. (1974) Arch. Biochem. Biophys. 163,426-428.
5. Schwartz, B. A. & Gray, G. R. (1977) Arch. Biochem. Biophys. 29. Galanos, C., Luderitz, O., Rietschel, E. T. & Westphal, 0. (1977)
Int. Rev. Biochem. 14,239-335.
181, 542-549.
6. Kamicker, B. J., Schwartz, B. A., Olson, R. M., Drinkwitz, D. 30. Akazawa, H. (1968) Bull. Jpn Soc. Sci.Fish. 34, 240-246.
31. Abe, P. M. (1973) M. Sc. Thesis, Oregon State University.
C. & Gray, G. R. (1977) Arch. Biochem. Biophys. 183, 39332. Miller, J . M., Spilsbury, J. F., Jones, R. J.. Roe, E. A. & Lowbury.
398.
7. Kleinhammer, G., Himmelspach, K . & Westphal, 0. (1973) Eur.
E. J. L. (1977) J. Med. Microhiol. 10, 19-27.
33. Vande Wiel, P. A,, Witvlict, M. H., Evenberg, D., Derks, H. J.
J . Immunol. 3, 834-838.
G. M. & Coen Beuvcry, E. (1987) Vaccine 5 , 33-37.
8. Roy, R., Katzenellenbogen, E. & Jennings, H. J. (1984) Can. J .
34. Martodam, R. R., Twumasi, D. Y., Liener, I. E., Powers, J. C.,
Biochem. Cell B i d . 62, 270 - 215.
Nishimo, N. & Krejcarek (1979) Proc. Natl Acad. Sci. USA 76,
9. Banoub, J. H. & Hodder, H. J. (1985) Cun. J . Biochem. CeN B i d .
63, 1199- 1205.
2128 -2132.
35. Lemieux, R. U., Baker, D. A. & Bundle, D. R. (1975) J . Am.
10. Banoub, J. H., Shaw, D. H. & Michon, F. (1983) Carhohydr. R e x
123, 117-122.
Chem. Soc. 97,4076-4083.
11. Shaw, D . H., Squircs, M. J., Ishiguro, E. E. & Trust, T. J. (1986) 36. Lemieux, R. U.. Raker, D. A. & Bundle, D. R. (1977) Cun. J .
Eur. J. Biochem. 161, 309-313.
Biochem. 55, 507-512.
12. Banoub, J. H., Michon, F. & Hodder, H. J. (1987) Biochem. Cell 37. Jennings, H . J. & Lugowski, C. (1981) J . Immunol 127, 1011B i d . 6.5,19- 26.
1018.
(1 + 4)-linked 3-acetamido-3,6-dideoxy-~-~-glucose
alternately substituted through 0 - 2 with side-chain residues of
2-acetamido-2,6-dideoxy-~-glucose,
which are extremely acidlabile. The mild conditions used in the present coupling procedure allowed the conjugation of this acid-sensitive modified
lipopolysaccharide to the macromolecular protein carrier. In
addition, this method does not grossly affect the immunogenic
specificities of the carrier protein as the resulting glycoconjugates eluted as a single peak in gel chromatography,
indicating that no cross-linking or major alterations of the
carrier protein had occurred [19]. To our knowledge, this is
the first instance where a lipopolysaccharide of any sort has
been covalently conjugated to a carrier protein.
It is anticipated that the 0-specific-polysaccharide- albumin and modified-lipopolysaccharide - albumin glycoconjugates may be used as potential fish vaccines and that the
antisera produced will possess good bacteriostatic activity
against the homologous organisms.
zyxwvutsrqp
zyxwvutsrqp
zyxwvutsr
zy
zyxwvutsrqp